Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline
James D. Chalmers, Megan Crichton, Pieter Goeminne, et al.
European Respiratory Journal (2021) Vol. 57, Iss. 4, pp. 2100048-2100048
Open Access | Times Cited: 201

Showing 1-25 of 201 citing articles:

Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial
Stéphan Ehrmann, Jie Li, Miguel Ibarra‐Estrada, et al.
The Lancet Respiratory Medicine (2021) Vol. 9, Iss. 12, pp. 1387-1395
Open Access | Times Cited: 203
European Respiratory Society statement on long COVID follow-up
Katerina M. Antoniou, Eirini Vasarmidi, Anne‐Marie Russell, et al.
European Respiratory Journal (2022) Vol. 60, Iss. 2, pp. 2102174-2102174
Open Access | Times Cited: 123
Prospective longitudinal evaluation of hospitalised COVID-19 survivors 3 and 12 months after discharge
Natalie Lorent, Yannick Vande Weygaerde, Eveline Claeys, et al.
ERJ Open Research (2022) Vol. 8, Iss. 2, pp. 00004-2022
Open Access | Times Cited: 81
Early noninvasive ventilation in general wards for acute respiratory failure: an international, multicentre, open-label, randomised trial
Giacomo Monti, Luca Cabrini, Yuki Kotani, et al.
British Journal of Anaesthesia (2025)
Closed Access | Times Cited: 1
Noninvasive respiratory support outside the intensive care unit for acute respiratory failure related to coronavirus-19 disease: a systematic review and meta-analysis
Gianmaria Cammarota, Teresa Esposito, Danila Azzolina, et al.
Critical Care (2021) Vol. 25, Iss. 1
Open Access | Times Cited: 80
Respiratory rehabilitation for Covid-19 related persistent dyspnoea: A one-year experience
Benoit Bouteleux, Pauline Henrot, Rachel Ernst, et al.
Respiratory Medicine (2021) Vol. 189, pp. 106648-106648
Open Access | Times Cited: 61
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients
Adam Cuker, Eric Tseng, Robby Nieuwlaat, et al.
Blood Advances (2022) Vol. 6, Iss. 17, pp. 4915-4923
Open Access | Times Cited: 56
The use of non-steroidal anti-inflammatory drugs (NSAIDs) in COVID-19
Pamela Kushner, Bill McCarberg, Laurent Grange, et al.
npj Primary Care Respiratory Medicine (2022) Vol. 32, Iss. 1
Open Access | Times Cited: 42
Elevated plasma levels of epithelial and endothelial cell markers in COVID-19 survivors with reduced lung diffusing capacity six months after hospital discharge
Oriol Sibila, Lídia Perea, Núria Albacar, et al.
Respiratory Research (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 38
The intersection of obesity and (long) COVID-19: Hypoxia, thrombotic inflammation, and vascular endothelial injury
Mengqi Xiang, Xiaoming Wu, Haijiao Jing, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 38
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients
Adam Cuker, Eric Tseng, Holger J. Schünemann, et al.
Blood Advances (2022) Vol. 6, Iss. 17, pp. 4975-4982
Open Access | Times Cited: 37
Remdesivir: A Review in COVID-19
Hannah A. Blair
Drugs (2023) Vol. 83, Iss. 13, pp. 1215-1237
Open Access | Times Cited: 28
Antiviral Therapy of COVID-19
Georgii Gudima, И.А. Кофиади, I.P. Shilovskiy, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8867-8867
Open Access | Times Cited: 24
Effectiveness of Remdesivir, Lopinavir/Ritonavir, and Favipiravir for COVID-19 Treatment: A Systematic Review
Windi Fresha Qomara, Delya Nur Primanissa, Salma Hasni Amalia, et al.
International Journal of General Medicine (2021) Vol. Volume 14, pp. 8557-8571
Open Access | Times Cited: 53
Clinical presentation, disease course, and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across 18 countries
Marijke Linschoten, Alicia Uijl, Astrid Schut, et al.
European Heart Journal (2021) Vol. 43, Iss. 11, pp. 1104-1120
Open Access | Times Cited: 49
ROX index as predictor of high flow nasal cannula therapy success in acute respiratory failure due to SARS-CoV-2
Santos Ferrer, Jesús Sancho, Irene Bocigas, et al.
Respiratory Medicine (2021) Vol. 189, pp. 106638-106638
Open Access | Times Cited: 44
Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19: a randomised double-blinded placebo-controlled trial
Pradeesh Sivapalan, Charlotte Suppli Ulrik, Thérèse Sophie Lapperre, et al.
European Respiratory Journal (2021) Vol. 59, Iss. 1, pp. 2100752-2100752
Open Access | Times Cited: 43
Melatonin as a Potential Adjuvant Treatment for COVID-19 beyond Sleep Disorders
Adam Wichniak, Aleksander Kania, Mariusz Siemiński, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8623-8623
Open Access | Times Cited: 43
Monoclonal antibody therapies in the management of SARS-CoV-2 infection
Enrique Míguez‐Rey, Dasom Choi, Seungmin Kim, et al.
Expert Opinion on Investigational Drugs (2022) Vol. 31, Iss. 1, pp. 41-58
Open Access | Times Cited: 35
Update June 2022: management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline
Nicolás Roche, Megan Crichton, Pieter Goeminne, et al.
European Respiratory Journal (2022) Vol. 60, Iss. 2, pp. 2200803-2200803
Open Access | Times Cited: 34
Prolonged higher dose methylprednisoloneversusconventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS)
Francesco Salton, Paola Confalonieri, Stefano Centanni, et al.
European Respiratory Journal (2022) Vol. 61, Iss. 4, pp. 2201514-2201514
Open Access | Times Cited: 33
Respiratory viruses: their importance and lessons learned from COVID-19
Catia Cillóniz, Carlos M. Luna, Juan Carlos Hurtado, et al.
European Respiratory Review (2022) Vol. 31, Iss. 166, pp. 220051-220051
Open Access | Times Cited: 32
The Efficacy and Safety of Janus Kinase Inhibitors for Patients With COVID-19: A Living Systematic Review and Meta-Analysis
Xueyang Zhang, Lianhan Shang, Guohui Fan, et al.
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 28
Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study
Luis Felipe Reyes, Srinivas Murthy, Esteban García-Gallo, et al.
Critical Care (2022) Vol. 26, Iss. 1
Open Access | Times Cited: 27
Risk factors for developing ventilator-associated lower respiratory tract infection in patients with severe COVID-19: a multinational, multicentre study, prospective, observational study
Luis Felipe Reyes, Alejandro Rodríguez, Yuli V. Fuentes, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top